Cardiac involvement in severe cutaneous adverse reactions: a retrospective observational cohort study of drug reaction with eosinophilia and systemic symptoms and Stevens–Johnson syndrome/toxic epidermal necrolysis at a major Australian tertiary hospital
Clinical and Experimental Dermatology · 2026
DOI: 10.1093/ced/llag222 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Clinical and Experimental Dermatology, 2026. Verfasst von Sang Jin Han und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, Alfred Health, Melbourne, VIC, Australia. Hauptthemen laut MEDLINE: Stevens-Johnson Syndrome, Drug Hypersensitivity Syndrome, Heart Diseases. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Drug reaction with eosinophilia and systemic symptoms (DRESS), Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening adverse medication reactions, often with multiorgan involvement. Cardiac involvement in these conditions has not been well characterized.
Objectives
To evaluate the prevalence, clinical spectrum and outcomes of cardiac involvement in patients diagnosed with DRESS and SJS/TEN.
Methods
A single-centre retrospective cohort study was conducted. Patients with DRESS or SJS/TEN seen between January 2014 and January 2024 were identified through the hospital adverse drug reaction database. Cardiac involvement was defined as the presence of cardiac symptoms accompanied by any new abnormality detected on electrocardiograms, cardiac biomarkers and/or cardiac imaging during admission.
Results
In total, 158 patients were included: 79 with DRESS and 79 with SJS/TEN. Cardiac involvement was identified in 15% of cases of DRESS and 6% of cases of SJS/TEN. Cardiovascular risk factors were prevalent across both conditions, with hypertension being the most common. Cardiac symptoms were reported in up to 20% of cases, with dyspnoea being the most frequent. Of those who had cardiac investigations, new electrocardiographic abnormalities were detected in up to 42% of patients. Intensive care unit (ICU) admissions and mortality were higher with SJS/TEN, but there was no mortality attributable to cardiac involvement. Antibiotics were the most frequently implicated medications in both groups. In the DRESS subgroup analysis, cardiac involvement was associated with higher rates of renal involvement (100% vs. 64%, P = 0.01) and ICU admission [67% vs. 34%, odds ratio (OR) 3.83, 95% confidence interval (CI) 1.04–14.1; P = 0.04], but was less common with antibiotic exposure as a cause of DRESS (58% vs. 84%, OR 0.28, 95% CI 0.07–1.03; P = 0.06).
Conclusions
Cardiac involvement is an under-recognized but clinically important feature of DRESS and SJS/TEN. Our findings highlight the contribution of cardiac dysfunction to morbidity and support routine cardiac assessment in patients with severe cutaneous adverse reactions. Larger prospective studies and national drug reaction registries are needed to better define the burden and guide care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of General Medicine, Alfred Health, Melbourne, VIC, Australia.
- School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
- Department of Dermatology, Alfred Health, Melbourne, VIC, Australia.
- Pharmacy Department, Alfred Health, Melbourne, VIC, Australia.
- School of Translational Medicine, Monash University, Melbourne, VIC, Australia.
- Department of Allergy, Immunology and Respiratory Medicine, Alfred Health, Melbourne, VIC, Australia.
ORCID-Profile: Sang Jin Han, Ayooluwatomiwa I Oloruntoba, Linda Graudins, Michelle S Goh, Johannes S Kern, Ar Kar Aung
Zitieren
APA
Han, S. J., Oloruntoba, A. I., Meng, A., Bosco, T., Paul, E., Graudins, L., Goh, M. S., Kern, J. S., Zubrinich, C., & Aung, A. K. (2026). Cardiac involvement in severe cutaneous adverse reactions: a retrospective observational cohort study of drug reaction with eosinophilia and systemic symptoms and Stevens–Johnson syndrome/toxic epidermal necrolysis at a major Australian tertiary hospital. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llag222
Vancouver
Han SJ, Oloruntoba AI, Meng A, Bosco T, Paul E, Graudins L, et al. Cardiac involvement in severe cutaneous adverse reactions: a retrospective observational cohort study of drug reaction with eosinophilia and systemic symptoms and Stevens–Johnson syndrome/toxic epidermal necrolysis at a major Australian tertiary hospital. Clinical and Experimental Dermatology. 2026. doi:10.1093/ced/llag222
BibTeX
@article{Han2026,
author = {Han, Sang Jin and Oloruntoba, Ayooluwatomiwa I and Meng, Angela and Bosco, Thea and Paul, Eldho and Graudins, Linda and Goh, Michelle S and Kern, Johannes S and Zubrinich, Celia and Aung, Ar Kar},
title = {Cardiac involvement in severe cutaneous adverse reactions: a retrospective observational cohort study of drug reaction with eosinophilia and systemic symptoms and Stevens–Johnson syndrome/toxic epidermal necrolysis at a major Australian tertiary hospital},
journal = {Clinical and Experimental Dermatology},
year = {2026},
doi = {10.1093/ced/llag222}
}
EUVIMED